Answer
Mar 06, 2026 - 11:25 AM
Yes, the risk of adverse reactions may be increased in patients with moderate liver impairment. This is valuable information for safety and helps ensure patients are monitored appropriately.
Do you have the same question? Follow this Question
Mar 06, 2026 - 11:25 AM